Trials / Completed
CompletedNCT00609284
Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 406 (actual)
- Sponsor
- Groupe Oncologie Radiotherapie Tete et Cou · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the trial is to study the efficacy of adding concomitant chemotherapy (carboplatin/5FU) to Erbitux-radiotherapy in patients with locally advanced head and neck cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | cetuximab | D-7, D1, D8, D15, D22, D29, D43, D50 |
| DRUG | Carboplatin, 5FU concomitant | Carboplatin 70mg/m²/D ; 5FU 600 mg/m²/D, D1-4, D22-25, D43-46 |
| RADIATION | Radiotherapy | 70 Gy in 7 weeks |
Timeline
- Start date
- 2008-02-15
- Primary completion
- 2018-03-26
- Completion
- 2019-03-26
- First posted
- 2008-02-07
- Last updated
- 2020-04-15
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00609284. Inclusion in this directory is not an endorsement.